white house glp-1 Weight-loss drug makers announce pricing agreement with Trump WATCH: President Trump Announces Major

Schedule a Consultation What's Your Next Journey

By addressing both weight and blood sugar levels, GLP-1 therapy provides a comprehensive approach to diabetes management

Eisenberg MA, Deboever N, Mills AC, Egyud MR, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG , Walsh GL, Vaporciyan AA, Antonoff MB

The published Phase 3 mean weight reduction for retatrutide (28.3%) is nearly double the figure for semaglutide in STEP-1 (14.9%) over comparable trial durations

ShiHGeXMaXZhengMCuiXPanWet al

however, the same reduction in cardiovascular deaths versus a placebo could be achieved at a lower cost through alternate therapies